Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration

Experimental Cell Research

Volumn 315, Issue 15, 2009, Pages 2505-2514

  Heering, Johanna ^a   Erlmann, Patrik ^a   Olayioye, Monilola A ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

Breast cancer; Cell migration; Lipid phosphatase; Rho GTPase activating protein; Tumor suppressor

Indexed keywords

DELETED IN LIVER CANCER 1 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN DLC1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOMA CELL; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WOUND HEALING;

EID: 67651008260     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.05.022     Document Type: Article

References (50)

1. Salmena L., Carracedo A., and Pandolfi P.P. Tenets of PTEN tumor suppression. Cell 133 (2008) 403-414
2. Kim R.H., and Mak T.W. Tumours and tremors: how PTEN regulation underlies both. Br. J. Cancer 94 (2006) 620-624
3. Feilotter H.E., Coulon V., McVeigh J.L., Boag A.H., Dorion-Bonnet F., Duboue B., Latham W.C., Eng C., Mulligan L.M., and Longy M. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma. Br. J. Cancer 79 (1999) 718-723
4. Garcia J.M., Silva J.M., Dominguez G., Gonzalez R., Navarro A., Carretero L., Provencio M., Espana P., and Bonilla F. Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype. Breast Cancer Res. Treat. 57 (1999) 237-243
5. Depowski P.L., Rosenthal S.I., and Ross J.S. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer. Mod. Pathol. 14 (2001) 672-676
6. Perren A., Weng L.P., Boag A.H., Ziebold U., Thakore K., Dahia P.L., Komminoth P., Lees J.A., Mulligan L.M., Mutter G.L., and Eng C. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am. J. Pathol. 155 (1999) 1253-1260
7. Saal L.H., Holm K., Maurer M., Memeo L., Su T., Wang X., Yu J.S., Malmstrom P.O., Mansukhani M., Enoksson J., Hibshoosh H., Borg A., and Parsons R. P.I.K.3.C.A. mutations correlate with hormone receptors node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res. 65 (2005) 2554-2559
8. Suzuki A., de la Pompa J.L., Stambolic V., Elia A.J., Sasaki T., del B.B., Ho I.A., Wakeham A., Itie A., Khoo W., Fukumoto M., and Mak T.W. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8 (1998) 1169-1178
9. Stambolic V., Suzuki A., de la Pompa J.L., Brothers G.M., Mirtsos C., Sasaki T., Ruland J., Penninger J.M., Siderovski D.P., and Mak T.W. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95 (1998) 29-39
10. Di Cristofano A., Pesce B., Cordon-Cardo C., and Pandolfi P.P. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19 (1998) 348-355
11. Stambolic V., Tsao M.S., Macpherson D., Suzuki A., Chapman W.B., and Mak T.W. High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer Res. 60 (2000) 3605-3611
12. Podsypanina K., Ellenson L.H., Nemes A., Gu J., Tamura M., Yamada K.M., Cordon-Cardo C., Catoretti G., Fisher P.E., and Parsons R. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. U. S. A 96 (1999) 1563-1568
13. Li G., Robinson G.W., Lesche R., Martinez-Diaz H., Jiang Z., Rozengurt N., Wagner K.U., Wu D.C., Lane T.F., Liu X., Hennighausen L., and Wu H. Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 129 (2002) 4159-4170
14. Maehama T., Taylor G.S., and Dixon J.E. PTEN and myotubularin: novel phosphoinositide phosphatases. Annu. Rev. Biochem. 70 (2001) 247-279
15. Manning B.D., and Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 129 (2007) 1261-1274
16. Yuan B.Z., Miller M.J., Keck C.L., Zimonjic D.B., Thorgeirsson S.S., and Popescu N.C. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res. 58 (1998) 2196-2199
17. Durkin M.E., Yuan B.Z., Zhou X., Zimonjic D.B., Lowy D.R., Thorgeirsson S.S., and Popescu N.C. DLC-1: a Rho GTPase-activating protein and tumour suppressor. J. Cell Mol. Med. 11 (2007) 1185-1207
18. Lahoz A., and Hall A. DLC1: a significant GAP in the cancer genome. Genes Dev. 22 (2008) 1724-1730
19. Healy K.D., Hodgson L., Kim T.Y., Shutes A., Maddileti S., Juliano R.L., Hahn K.M., Harden T.K., Bang Y.J., and Der C.J. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms. Mol. Carcinog. 47 (2008) 326-337
20. Wong C.M., Lee J.M., Ching Y.P., Jin D.Y., and Ng I.O. Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res. 63 (2003) 7646-7651
21. Jaffe A.B., and Hall A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21 (2005) 247-269
22. Ridley A.J. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 16 (2006) 522-529
23. Xue W., Krasnitz A., Lucito R., Sordella R., Vanaelst L., Cordon-Cardo C., Singer S., Kuehnel F., Wigler M., Powers S., Zender L., and Lowe S.W. DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes Dev. 22 (2008) 1439-1444
24. Holeiter G., Heering J., Erlmann P., Schmid S., Jahne R., and Olayioye M.A. Deleted in liver cancer 1 controls cell migration through a Dia1-dependent signaling pathway. Cancer Res. 68 (2008) 8743-8751
25. Ridley A.J., Schwartz M.A., Burridge K., Firtel R.A., Ginsberg M.H., Borisy G., Parsons J.T., and Horwitz A.R. Cell migration: integrating signals from front to back. Science 302 (2003) 1704-1709
26. Scholz R.P., Regner J., Theil A., Erlmann P., Holeiter G., Jahne R., Schmid S., Hausser A., and Olayioye M.A. DLC1 interacts with 14-3-3 proteins to inhibit RhoGAP activity and block nucleocytoplasmic shuttling. J. Cell Sci. 122 (2009) 92-102
27. Kolsch V., Charest P.G., and Firtel R.A. The regulation of cell motility and chemotaxis by phospholipid signaling. J. Cell Sci. 121 (2008) 551-559
28. Leslie N.R., Yang X., Downes C.P., and Weijer C.J. The regulation of cell migration by PTEN. Biochem. Soc. Trans. 33 (2005) 1507-1508
29. Tamura M., Gu J., Matsumoto K., Aota S., Parsons R., and Yamada K.M. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280 (1998) 1614-1617
30. Sekimata M., Kabuyama Y., Emori Y., and Homma Y. Morphological changes and detachment of adherent cells induced by p122, a GTPase-activating protein for Rho. J. Biol. Chem. 274 (1999) 17757-17762
31. Ginn-Pease M.E., and Eng C. Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells. Cancer Res. 63 (2003) 282-286
32. Vazquez F., and Devreotes P. Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction. Cell Cycle 5 (2006) 1523-1527
33. Odriozola L., Singh G., Hoang T., and Chan A.M. Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J. Biol. Chem. 282 (2007) 23306-23315
34. Li Y., Podsypanina K., Liu X., Crane A., Tan L.K., Parsons R., and Varmus H.E. Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice. BMC Mol. Biol. 2 (2001) 2
35. Dourdin N., Schade B., Lesurf R., Hallett M., Munn R.J., Cardiff R.D., and Muller W.J. Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis. Cancer Res. 68 (2008) 2122-2131
36. Liao Y.C., Shih Y.P., and Lo S.H. Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function. Cancer Res. 68 (2008) 7718-7722
37. Weng L.P., Smith W.M., Dahia P.L., Ziebold U., Gil E., Lees J.A., and Eng C. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Cancer Res. 59 (1999) 5808-5814
38. Yuan B.Z., Zhou X., Durkin M.E., Zimonjic D.B., Gumundsdottir K., Eyfjord J.E., Thorgeirsson S.S., and Popescu N.C. DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity. Oncogene 22 (2003) 445-450
39. Funamoto S., Meili R., Lee S., Parry L., and Firtel R.A. Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell 109 (2002) 611-623
40. Iijima M., and Devreotes P. Tumor suppressor PTEN mediates sensing of chemoattractant gradients. Cell 109 (2002) 599-610
41. Wessels D., Lusche D.F., Kuhl S., Heid P., and Soll D.R. PTEN plays a role in the suppression of lateral pseudopod formation during Dictyostelium motility and chemotaxis. J. Cell Sci. 120 (2007) 2517-2531
42. Liliental J., Moon S.Y., Lesche R., Mamillapalli R., Li D., Zheng Y., Sun H., and Wu H. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr. Biol. 10 (2000) 401-404
43. Suzuki A., Kaisho T., Ohishi M., Tsukio-Yamaguchi M., Tsubata T., Koni P.A., Sasaki T., Mak T.W., and Nakano T. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J. Exp. Med. 197 (2003) 657-667
44. Lacalle R.A., Gomez-Mouton C., Barber D.F., Jimenez-Baranda S., Mira E., Martinez A., Carrera A.C., and Manes S. P.T.E.N. regulates motility but not directionality during leukocyte chemotaxis. J. Cell Sci. 117 (2004) 6207-6215
45. Nishio M., Watanabe K., Sasaki J., Taya C., Takasuga S., Iizuka R., Balla T., Yamazaki M., Watanabe H., Itoh R., Kuroda S., Horie Y., Forster I., Mak T.W., Yonekawa H., Penninger J.M., Kanaho Y., Suzuki A., and Sasaki T. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1. Nat. Cell Biol. 9 (2007) 36-44
46. Raftopoulou M., Etienne-Manneville S., Self A., Nicholls S., and Hall A. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 303 (2004) 1179-1181
47. Yam J.W., Ko F.C., Chan C.Y., Jin D.Y., and Ng I.O. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression. Cancer Res. 66 (2006) 8367-8372
48. Qian X., Li G., Asmussen H.K., Asnaghi L., Vass W.C., Braverman R., Yamada K.M., Popescu N.C., Papageorge A.G., and Lowy D.R. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 9012-9017
49. Kim C.A., and Bowie J.U. SAM domains: uniform structure, diversity of function. Trends Biochem. Sci. 28 (2003) 625-628
50. Li Z., Dong X., Wang Z., Liu W., Deng N., Ding Y., Tang L., Hla T., Zeng R., Li L., and Wu D. Regulation of PTEN by Rho small GTPases. Nat. Cell Biol. 7 (2005) 399-404